Virios Therapeutics Announces Positive Data Demonstrating

ATLANTA, July 17, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on...

Related Keywords

Lucinda Bateman ,R Michael Gendreau ,Nasdaq ,Facebook ,Linkedin ,Exchange Commission ,Bateman Horne Center ,Virios Therapeutics Inc ,Drug Administration ,Brookings Institute ,Twitter ,Post Acute Sequelae ,Orthostatic Intolerance ,Global Impression ,Medical Director ,Chief Medical Officer ,Securities Litigation Reform Act ,Virios Therapeutic ,Annual Report ,Virios Therapeutics ,Nasdaq Viri ,Siri ,Ibro ,Fibromyalgia ,Clinical Trials ,Longcovid ,Fatigue ,